Yuki Onoe - Blogs | Oblon Life Sciences Blog

AUTHORS

Stephen G. Baxter, Ph.D.
sbaxter@oblon.com
(703) 413-3000

Richard D. Kelly
rkelly@oblon.com
(703) 412-6241

James R. Love
jlove@oblon.com
(703) 412-6051

Marina I. Miller, Ph.D.
mmiller@oblon.com
(703) 412-6044

Daniel J. Pereira, Ph.D.
dpereira@oblon.com
(703) 413-6560

J. Derek Mason, Ph.D., CLP
dmason@oblon.com
(703) 413-3000

Jacob A. Doughty
jdoughty@oblon.com
(703) 413-2737

Jeffrey B. McIntyre
jmcintyre@oblon.com
(703) 412-6041

Lisa M. Mandrusiak
lmandrusiak@oblon.com
(703) 412-6492

Matthew E. Barnet, Ph.D.
mbarnet@oblon.com
(703) 413-2395

Todd W. Baker
tbaker@oblon.com
(703) 413-3000

Tia D. Fenton
tfenton@oblon.com
(703) 413-2777

Vincent K. Shier, Ph.D.
vshier@oblon.com
(703) 412-6461

Yuki Onoe
yonoe@oblon.com
+81-3-6212-0550

No matches found...

CATEGORIES

Pharma Alice Standard Federal Circuit USPTO PTAB Rules Cannabis Supreme Court Patent Eligibility 101 Mayo Myriad Gene Segments IPR Antibodies AI Artificial Intelligence Life Cycle Management

STAY UPDATED

Delivered by FeedBurner

Copyright © Oblon, McClelland, Maier & Neustadt, L.L.P. | Disclaimer

The opinions, commentary and characterizations provided to this online forum by the authors and moderators are provided for encouraging discussion, thought and debate on important design patent issues. These postings are in no way representative of the opinions of the Oblon firm, or its clients, but rather the personal views of the individual authors.

Hosted on the FirmWise platform.